Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Mid-range Performer
1014.2000 -14.60 (-1.42%)
NSE Jun 13, 2025 15:31 PM
Volume: 79,030
 

logo
Alivus Life Sciences Ltd.
16 Jul 2024
1014.20
-1.42%
buy
by Hem Securities
Target: 987 | Target met
Hem Securities
 
Alivus Life Sciences.. has an average target of 1152.00 from 2 brokers.
More from Alivus Life Sciences Ltd.
Recommended
Five Interesting Stocks Today - June 13, 2025
The Baseline | 13 Jun 2025, 04:44PM
Market closes lower, NCLT admits IREDA’s insolvency plea against Gensol Engineering
Trendlyne Marketwatch | 13 Jun 2025, 04:01PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021